Evidence map›Paper›PMID 33381562›Full record

ArticleBioMed research international2020

Assessing the Anti-inflammatory Mechanism of Reduning Injection by Network Pharmacology.

Fuda Xie, Mingxiang Xie, Yibing Yang, Miaomiao Zhang, Xiaojie Xu, Na Liu, Wei Xiao, Jiangyong Gu

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Clinical Observation of Reduning Combined with Recombinant Human InterferonEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Fuda XieResearch Center of Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.ORCID https://orcid.org/0000-0001-9189-828X
Mingxiang XieResearch Center of Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Yibing YangResearch Center of Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Miaomiao ZhangThe Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Xiaojie XuCollege of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.
Na LiuResearch Center of Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
Wei XiaoState Key Laboratory of New-Tech for Chinese Medicine Pharmaceutical Process, Lianyungang 222001, China.ORCID https://orcid.org/0000-0001-8809-9137
Jiangyong GuResearch Center of Integrative Medicine, School of Basic Medical Science, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.ORCID https://orcid.org/0000-0002-3654-2640
Guangzhou University of Chinese Medicine · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reduning Injection (RDNI) is a traditional Chinese medicine formula indicated for the treatment of inflammatory diseases. However, the molecular mechanism of RDNI is unclear. The information of RDNI ingredients was collected from previous studies. Targets of them were obtained by data mining and molecular docking. The information of targets and related pathways was collected in UniProt and KEGG. Networks were constructed and analyzed by Cytoscape to identify key compounds, targets, and pathways. Data mining and molecular docking identified 11 compounds, 84 targets, and 201 pathways that are related to the anti-inflammatory activity of RDNI. Network analysis identified two key compounds (caffeic acid and ferulic acid), five key targets (Bcl-2, eNOS, PTGS2, PPARA, and MMPs), and four key pathways (estrogen signaling pathway, PI3K-AKT signaling pathway, cGMP-PKG signaling pathway, and calcium signaling pathway) which would play critical roles in the treatment of inflammatory diseases by RDNI. The cross-talks among pathways provided a deeper understanding of anti-inflammatory effect of RDNI. RDNI is capable of regulating multiple biological processes and treating inflammation at a systems level. Network pharmacology is a practical approach to explore the therapeutic mechanism of TCM for complex disease.

Indexed as

Molecular Docking SimulationAlgorithmsAnti-Inflammatory AgentsCaffeic AcidsCoumaric AcidsData MiningDrugs, Chinese HerbalEstrogensHumansInflammationMedicine, Chinese TraditionalPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRegistriesSignal TransductionAKT1 protein, humanAnti-Inflammatory Agentscaffeic acidCaffeic AcidsCoumaric AcidsDrugs, Chinese HerbalEstrogensferulic acidPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktreduning

Identifiers

PMID33381562
PMCPMC7758122
OpenAlexW3110667189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.